Fridell RA, Qiu D, Wang C, Valera L, Gao M. . Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon syste. Antimicrob Agents Chemother. 2010. 54(9). 3641-3650 . Find at Google Scholar.
Hui-Mei Lin, Jing-Chyi Wang, Han-Shu Hu, Pei-Shan Wu, Chi-Chen Yang, Chung-Pu Wu, Szu-Yuan Pu, Tsu-A. Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C viru. Antimicrob Agents Chemother . 2012. 56(1). 44-53. Find at Google Scholar.
Wang C, Huang H, Valera L, Sun JH, OBoyle DR 2nd, Nower PT, Jia L, Qiu D, Huang X, Altaf A, Gao M, F. Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-7. Antimicrob Agents Chemother . 2012. 56(3). 1350-1358. Find at Google Scholar.
Lin HM, Wang JC, Hu HS, Wu PS, Wang WH, Wu SY, Yang CC, Yeh TK, Hsu TA, Jiaang WT, Chao YS, Chern JH. Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor. Antimicrob Agents Chemother. 2013. 57(2). 723-733. Find at Google Scholar.
Peres-da-Silva A, Almeida A, Lampe E. . NS5A inhibitor resistance-associated polymorphism in Brazilian treatment-naive patients infected wit. J. Antimicrob Chemother. 2014. 70(3). 726-730. Find at Google Scholar.